SEARCH

SEARCH BY CITATION

References

  • Belyansky, I., Tsirline, V.B., Martin, T.R., Klima, D.A., Heath, J., Lincourt, A.E., Satishkumar, R., Vertegel, A. et al. (2011) The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength. J Surg Res 171, 409415.
  • Busilacchi, A., Gigante, A., Mattioli-Belmonte, M., Manzotti, S. and Muzzarelli, R.A. (2013) Chitosan stabilizes platelet growth factors and modulates stem cell differentiation toward tissue regeneration. Carbohydr Polym 98, 665676.
  • Climo, M.W., Patron, R.L., Goldstein, B.P. and Archer, G.L. (1998) Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob Agents Chemother 42, 13551360.
  • Cui, F., Li, G., Huang, J., Zhang, J., Lu, M., Lu, W. and Huang, Q. (2010) Extension of nasal anti–Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan–o/w cream. Drug Deliv 17, 617623.
  • Cui, F., Li, G., Huang, J., Zhang, J., Lu, M., Lu, W., Husan, J. and Huang, Q. (2011) Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties. Drug Deliv 18, 173180.
  • Dajcs, J.J., Hume, E.B.H., Moreau, J.M., Caballero, A.R., Cannon, B.M. and O'Callaghan, R.J. (2000) Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci 41, 14321437.
  • Desbois, A.P., Gemmell, C.G. and Coote, P.J. (2010) In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic methicillin-resistant Staphylococcus aureus (MRSA) infections. Int J Antimicrob Agents 35, 559565.
  • Fry, D.E. (2013) The continued challenge of Staphylococcus aureus in the surgical patient. Am Surg 79, 110.
  • Gorczyca, G., Tylingo, R., Szweda, P., Augustin, E., Sadowska, M. and Milewski, S. (2013) Preparation and characterization of genipin cross-linked chitosan-collagen-gelatin scaffolds using CO2 solutions. Carbohydr Polym 102, 901911.
  • Goyal, N., Miller, A., Tripathi, M. and Parvizi, J. (2013) Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening. Bone Joint J 95, 49.
  • Iversen, O. and Grov, A. (1973) Studies on lysostaphin. Separation and characterization of three enzymes. Eur J Biochem 38, 293300.
  • Jayakumar, R., Prabaharan, M., Sudheesh Kumar, P.T., Nair, S.V. and Tamura, H. (2011) Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnol Adv 29, 322337.
  • Kolodziejska, I., Skierka, E., Sadowska, M., Kolodziejski, W. and Niecikowska, C. (2008) Effect of extracting time and temperature on yield of gelatin from different fish offal. Food Chem 107, 700706.
  • Lavrence, J.C. (1994) Dressings and wound infections. Am J Surg 167, 21S24S.
  • Lin, Y.C., Tan, F.J., Marra, K.G., Jan, S.S. and Liu, D.C. (2009) Synthesis and characterization of collagen/hyaluronan/chitosan composite sponges for potential biomedical applications. Acta Biomater 5, 25912600.
  • Ma, P.X. (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60, 184198.
  • Marova, I. and Kovar, J. (1993) Spectrophotometric detection of bacteriolytic activity of diluted lysostaphin solutions. Folia Microbiol 38, 153158.
  • Miao, J., Pangule, R.C., Paskaleva, E.E., Hwang, E.E., Kane, R.S., Linhardt, R.J. and Dordick, J.S. (2011) Lysostaphin–functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials 32, 95579567.
  • Mierau, I., Leij, P., Van Swam, I., Blommestein, B., Floris, E., Mond, J. and Smidt, E.J. (2005) Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin. Microb Cell Fact 4, 15.
  • Miller, J.M., Creazzo, J. and Witt, C. (1992) Wound healing: an introductory clinical approach. Contemp Pediatr Physician 1, 3842.
  • Nandagiri, V.K., Gentile, P., Chiono, V., Tonda-Turo, C., Matsiko, A., Ramtoola, Z., Montevecchi, F.M. and Ciardelli, G. (2011) Incorporation of PLGA nanoparticles into porous chitosan-gelatin scaffolds: influence on the physical properties and cell behavior. J Mech Behav Biomed Mater 4, 13181327.
  • Park, P.W., Senior, R.M., Griffin, G.L., Broekelmann, T.J., Mudd, M.S. and Mecham, R.P. (1995) Binding and degradation of elastin by the staphylolytic enzyme lysostaphin. Int J Biochem Cell Biol 27, 139146.
  • Sarem, M., Moztarzadeh, F. and Mozafari, M. (2013) How can genipin assist gelatin/carbohydrate chitosan scaffolds to act as replacements of load-bearing soft tissues? Carbohydr Polym 93, 635643.
  • Schindler, C.A. and Schuhardt, V.T. (1964) Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci USA 51, 414421.
  • Schleifer, K.H. and Kandler, O. (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36, 407477.
  • Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., Gottrup, F., Gurtner, G.C. et al. (2009) Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen 17, 763771.
  • Sjolund, M. and Kahlmeter, G. (2008) Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis 40, 894898.
  • Szweda, P., Lacka, I., Kotlowski, R. and Synowiecki, J. (2007) Protective effect of lysostaphin from Staphylococcus simulans against Staphylococcus aureus in milk and some other food products. J Food Saf 27, 265274.
  • Szweda, P., Schielmann, M., Kotlowski, R., Gorczyca, G., Zalewska, M. and Milewski, S. (2012) Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus. Appl Microbiol Biotechnol 96, 11571174.
  • Szweda, P., Gorczyca, G., Filipkowski, P., Zalewska, M. and Milewski, S. (2014a) Efficient production of Staphylococcus simulans lysostaphin in a benchtop bioreactor by a recombinant E. coli. Prep Biochem Biotechnol 44, 370381.
  • Szweda, P., Scheillman, M., Frankowska, A., Kot, B. and Zalewska, M. (2014b) Lysostaphin, nisin and polymyxin B as effective agents against antibiotic resistant Staphylococcus aureus strains isolated from cows with mastitis in the eastern Poland. J Vet Med Sci 76, 355362.
  • Walencka, E., Sadowska, B., Rozalska, S., Hryniewicz, W. and Rozalska, B. (2005) Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Pol J Microbiol 54, 191200.
  • Walencka, E., Sadowska, B., Rozalska, S., Hryniewicz, W. and Rozalska, B. (2006) Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin. Folia Microbiol 51, 381386.
  • Wu, J.A., Kusuma, C., Mond, J.J. and Kokai-Kun, J.F. (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47, 34073414.
  • Yan, L.P., Wang, Y.J., Ren, L., Wu, G., Caridade, S.G., Fan, J.B., Wang, L.Y., Ji, P.H. et al. (2010) Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications. J Biomed Mater Res A 95, 465475.
  • Zhao, H., Blazanovic, K., Choi, Y., Bailey-Kellogg, C. and Griswold, K.E. (2014) Gene and protein sequence optimization for high level production of fully active and a glycosylated lysostaphin in Pichia pastoris. Appl Environ Microbiol. 80, 27462753.